BIO-key reports FY2025 revenue $6.1M, net loss $4.6M; Q1'26 revenue up 37% YoY

BIO KEY INTERNATIONAL INC

FY2025 revenue $6.1M, down 12% YoY; net loss $4.6M ($0.69/sh) vs $4.3M ($2.09/sh) in 2024.
Preliminary Q1'26 revenue $2.2M, up 37% YoY and 80% vs Q4'25; expects break-even in 2026.
Cash $2.7M at year-end, up from $0.4M; book value $7.6M vs $3.8M.
Defense sector revenue over trailing 12 months exceeded $2.2M; new partnerships in India, Vietnam, Middle East, Nordics.
Operating expenses reduced 7% to $669K; SG&A down 11%.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

BIO KEY INTERNATIONAL INC reported financial results for fourth quarter and year ending December 31, 2025.

Period: fourth quarter and year ending December 31, 2025
Result: reported results

Exact text from the filing

On March 31,2026, BIO-key International, Inc. (the “Company”) issued a press release announcing its financial results for its fourth quarter and year ending December 31, 2025.

View on SEC.gov

1349 earnings releases filed in the last 30 days. Browse all earnings releases →

BIO KEY INTERNATIONAL INC filing history →

Source: SEC EDGAR

accession 0001437749-26-010506

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.